Circadian regulation of liver metabolism: experimental approaches in human, rodent, and cellular models.
Journal article
Daniels LJ. et al, (2023), Am J Physiol Cell Physiol, 325, C1158 - C1177
Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk
Journal article
Westcott F. et al, (2023), Atherosclerosis, 117237 - 117237
Hepatocyte mARC1 promotes fatty liver disease
Journal article
Lewis LC. et al, (2023), JHEP Reports, 5
MLX plays a key role in lipid and glucose metabolism in humans: evidence from in vitro and in vivo studies
Journal article
HODSON L., (2023), Metabolism: clinical and experimental
Nutritional regulation of hepatic de novo lipogenesis in humans.
Journal article
Cross E. et al, (2023), Curr Opin Clin Nutr Metab Care, 26, 65 - 71
An optimised protocol for the investigation of insulin signalling in a human cell culture model of adipogenesis.
Journal article
Gamwell JM. et al, (2023), Adipocyte
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept, randomized double-blind placebo-controlled trial
Journal article
TOMLINSON J., (2023), Nature Communications
Detection and alterations of acetylcarnitine (AC) in human liver by 1 H MRS at 3T after supplementation with l-carnitine.
Journal article
Savic D. et al, (2022), Magn Reson Med
Determining the temporal, dose, and composition effects of nutritional substrates in an in vitro model of intrahepatocellular triglyceride accumulation.
Journal article
Nagarajan SR. et al, (2022), Physiol Rep, 10
The PNPLA3 I148M variant increases intrahepatic lipolysis and beta oxidation and decreases de novo lipogenesis and hepatic mitochondrial function in vivo in humans
Conference paper
Luukkonen PK. et al, (2022), DIABETOLOGIA, 65, S76 - S76
Intrahepatic triglyceride content: influence of metabolic and genetics drivers.
Journal article
Dearlove DJ. and Hodson L., (2022), Curr Opin Clin Nutr Metab Care, 25, 241 - 247
The PNPLA3 I148M variant increases intrahepatic lipolysis and beta oxidation and decreases de novo lipogenesis and hepatic mitochondrial function in humans
Conference paper
Luukkonen P. et al, (2022), JOURNAL OF HEPATOLOGY, 77, S690 - S691
Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents.
Journal article
Hazlehurst JM. et al, (2022), Metabol Open, 14
The effects of endogenously‐ and exogenously‐induced hyperketonemia on exercise performance and adaptation
Journal article
Dearlove DJ. et al, (2022), Physiological Reports, 10
Obesity due to Steroid Receptor Coactivator-1 deficiency is associated with endocrine and metabolic abnormalities.
Journal article
Cacciottolo TM. et al, (2022), J Clin Endocrinol Metab
Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice.
Journal article
Pramfalk C. et al, (2022), J Intern Med
Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.
Journal article
Green CJ. et al, (2022), Eur J Endocrinol
β-Hydroxybutyrate Oxidation in Exercise Is Impaired by Low-Carbohydrate and High-Fat Availability
Journal article
ROBERTSON J., (2021), Frontiers of Medicine
Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism
Journal article
Nagarajan SR. et al, (2021), Proceedings of the Nutrition Society, 1 - 23